Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation (Q42164499)

17 October 2017

Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation (English)

1 reference

17 October 2017

Sebastian Beck Jørgensen

1

1 reference

17 October 2017

Jane Honeyman

2

1 reference

17 October 2017

Jonathan S Oakhill

3

1 reference

17 October 2017

Daniel Fazakerley

4

1 reference

17 October 2017

Jacqueline Stöckli

5

1 reference

17 October 2017

Bruce E Kemp

6

1 reference

17 October 2017

Gregory R Steinberg

7

1 reference

17 October 2017

12 May 2009

1 reference

American Journal of Physiology - Endocrinology and Metabolism

17 October 2017

1 reference

17 October 2017

297

1 reference

17 October 2017

1

1 reference

17 October 2017

E57-66

1 reference

Dimerization of resistin and resistin-like molecules is determined by a single cysteine

17 October 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Regulation of fasted blood glucose by resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

From mice to men: insights into the insulin resistance syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Prolonged exposure to resistin inhibits glucose uptake in rat skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Insulin increases cell surface GLUT4 levels by dose dependently discharging GLUT4 into a cell surface recycling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Mouse and human resistins impair glucose transport in primary mouse cardiomyocytes, and oligomerization is required for this biological action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Mechanisms regulating adipocyte expression of resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

IRS1-independent defects define major nodes of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Glucose transport and glucose transporters in muscle and their metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Resistin- and Obesity-associated metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases alpha and beta in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Role of resistin in diet-induced hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Resistin impairs basal and insulin-induced glycogen synthesis by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Regulation of insulin signalling, glucose uptake and metabolism in rat skeletal muscle cells upon prolonged exposure to resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Disulfide-dependent multimeric assembly of resistin family hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

GLUT4 vesicle recruitment and fusion are differentially regulated by Rac, AS160, and Rab8A in muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Abnormal glucose homeostasis due to chronic hyperresistinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Chapter 4 Preparation of Isolated Rat Liver Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Central resistin induces hepatic insulin resistance via neuropeptide Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Ciliary neurotrophic factor stimulates muscle glucose uptake by a PI3-kinase-dependent pathway that is impaired with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Activation of SOCS-3 by resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

AMPK-Mediated AS160 Phosphorylation in Skeletal Muscle Is Dependent on AMPK Catalytic and Regulatory Subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Insulin action and insulin resistance in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90744.2008

10.1152/AJPENDO.90744.2008

21 January 2018

Identifiers

DOI

1 reference

17 October 2017

1 reference